Impact of Lymphopenia Recovery After Chemoradiotherapy on Durvalumab Consolidation Therapy in Stage III NSCLC

por Kuge, Tomoki, Shiroyama, Takayuki, Tamiya, Akihiro, Tamiya, Motohiro, Kanazu, Masaki, Kinehara, Yuhei, Tanaka, Tsunehiro, Morimura, Osamu, Taniguchi, Yoshihiko, Niki, Toshie, Tetsumoto, Satoshi, Hayashi, Kazuhiko, Nishino, Kazumi, Nagatomo, Izumi, Kumanogoh, Atsushi
Publicado 2023

Pneumonitis During Durvalumab Consolidation Therapy Affects Survival in Stage III NSCLC

por Kinehara, Yuhei, Shiroyama, Takayuki, Tamiya, Akihiro, Tamiya, Motohiro, Minami, Seigo, Kanazu, Masaki, Morimura, Osamu, Niki, Toshie, Tetsumoto, Satoshi, Taniguchi, Yoshihiko, Kuge, Tomoki, Nishino, Kazumi, Nagatomo, Izumi, Kumanogoh, Atsushi, Tachibana, Isao
Publicado 2023